Chimeric antigen receptor (CAR) T cell-based targeting of #CD317 as a novel immunotherapeutic strategy against #glioblastoma. academic.oup.com/neuro-oncology… #btsm SNO

Check out the new publicly available HLA class I and II antigen atlas for #meningioma including functional characterization. Congratulations to Gioele Medici and Marian Neidert! And the amazing teams from Peptide-based Immunotherapy QBiC | @[email protected] DKFZ VomLaborInDiePraxis. link.springer.com/article/10.100…

July 19 is #GlioblastomaAwarenessDay. Let's shine a light on #glioblastoma, the most common primary #braintumour of adults. We continue to fight for better treatments & a better quality of life for those living with this devastating disease. #GBMDay #btsm OncoAlert National Brain Tumor Society

An explanation why Siglec-9 is an attractive therapeutic target in patients with #glioblastoma. Proud that our Alicia Buck & Tobias W. could contribute.

Still 3 days to #EANO2023, taking place Sept 21-24 in Rotterdam. Kick off with our Educational Day on Sept 21. Spend a day with peers while being inspired and gaining lots of new insightful knowledge! bit.ly/3sRytb4 #NeuroOncology #Neurosurgery #cancernurse #AHP #btsm

Congrats Max!

Congrats Jiawei!

Congratulations to our newly graduated PhDs Gioele Medici, Remi Weber and Thomas Look and all the best for your future! Fantastic work also from the supervisors Marian Neidert, Flavio Vasella and Tobias Weiss!

📊 Patrick Roth presented today at #SNO2023 in Vancouver, Canada, the updated results and molecular subgroup analyses from the EORTC-1709-BTG #MIRAGEtrial on #glioblastoma within the session "#ClinicalTrials - Non-Immunologic". More: sno2023.eventscribe.net/agenda.asp?sta… SNO

Very proud of Miaomiao Sun@Alidasun who presented her PhD work at #SNO2023 in Vancouver. Fantastic achievement! Watch out for the new cell therapy approach she presented

We are having a great time at #SNO2023 SNO and are grateful for the opportunity to present some of our ongoing research by posters and presentations. Tobias W. Miaomiao Sun Maximilian Mastall

#EANO is enjoying a fantastic #SNO2023 in Vancouver! SNO Editor - Neuro-Oncology Advances #NeuroOncology #btsm

Last week we had a wonderful time at our annual lab retreat with stimulating discussions! 🇨🇭

The SOLA-Stafette 2024 is coming closer. For the second time in a row, our lab is running with #SOLAgegenKrebs to support cancer research. Feel free to help us supporting the Comprehensive Cancer Center Zurich below. Looking forward to a fantastic race!

Last week I finally defended my PhD about CAR T cells against #glioblastoma. I am very grateful for everything I’ve learned during this time and for the continuous support of my PhD committee members and lab colleagues @usz_neurooncology. Excited for new challenges ahead!

In einer Studie der ETH Zürich Zürich und des USZ erwies sich ein bekanntes Antidepressivum als vielversprechende Lösung zur Behandlung aggressiver #Hirntumoren. #Glioblastom usz.ch/ein-antidepres…

We are beyond proud of our newest Nature Medicine paper! Using pharmacoscopy & in-silico drug MoA discovery, we show that the antidepressant Vortioxietine is effective in #Glioblastoma primary patient material and in mouse models. bit.ly/GBM_SL   #PersonalizedMedicine